Month: December 2023

Zhejiang university team develops knittable “icebear fibre”

https://www.science.org/doi/10.1126/science.adj8013 http://en.people.cn/n3/2023/1222/c90000-20113796.html A team of Chinese scientists has developed a knittable fiber with exceptional thermal insulation drawing inspiration from polar bear fur. According to a study published in Science, the encapsulated aerogel fiber is washable, dyeable, durable and well-suited for use in advanced textiles. Aerogel fibers typically lack the strength and stretchability required for weaving into cloths, and they lose their insulating properties in wet or humid conditions. The researchers from Zhejiang University took inspiration from the specialized fur of polar bears, which effectively keeps them warm and dry. The hair features a porous core enclosed within a dense shell structure. Mimicking the core-shell structure, the researchers created a strong aerogel fiber with lamellar pores, which effectively traps the infrared radiation close to the skin and maintains mechanical robustness, making it suitable for knitting or weaving. The fiber maintained its thermal insulation properties with minimal impact even after 10,000 repeated stretching cycles at 100 percent strain. The team of researchers tested the fiber in a thin sweater, which, despite being roughly one-fifth as thick as a down jacket, deliveredcomparable thermal insulating performance.

Huaibai Mining starts 600,000 t/a ethanol plant based on coke oven gas

http://www.cas.ac.cn/cm/202312/t20231229_4993320.shtml An ethanol production plant with an annual output of 600,000 tons has started trial production on December 28. The plant uses coke oven gas as raw material and produces anhydrous ethanol. This is claimed to be currently the largest industrial ethanol production facility in the world. The technology was developed by the CAS Dalian Institute of Chemical Physics under Academician Liu Zhongmin and by Shaanxi Yanchang Petroleum Group, the plant was built by Anhui Carbonxin Technology Co., Ltd. of the Huaibei Mining Group. Academician Liu Zhongmin’s team has been engaged in non-grain ethanol production research for a long time, and has cooperated with Shaanxi Yanchang Petroleum Group to develop a technology to synthesize absolute ethanol (DMTE) using syngas as raw material through dimethyl ether carbonylation and methyl acetate hydrogenation. Large-scale production of ethanol using coal, natural gas or steel plant gas as raw materials has been realised. Currently, DMTE Technology has signed technology implementation license contracts for 13 sets of industrial equipment. The photograph shows Huaibei Mining Group Anhui Carbon Xin Technology Co., Ltd.’s 600,000 tons/year ethanol production unit. (Photo provided by Dalian Institute of Chemical Physics, Chinese Academy of Sciences)

In 2022, China had more than 6,3 million researchers (FTE)

https://www.gov.cn/zhengce/jiedu/tujie/202312/content_6920562.htm On December 15, MOST published the “China Science and Technology Talent Development Report (2022)”. It   shows that the full-time equivalent of China’s R&D personnel has increased from 3.247 million person-years in 2012 to 6.354 million person-years in 2022, firmly ranking first in the world. The Report is the fifth publication in this series and is prepared and published every two years by the Ministry of Science and Technology (MOST). The Report points out that in recent years, China has been expanding the scale of scientific and technological talents, while focusing on optimizing the structure of scientific and technological talents, creating a diversified, multi-level talent team, accelerating the construction of a clear positioning, enhanced effectiveness, and a reasonable ladder of strategic scientists, scientific and technological leaders, as well as innovation teams, young scientific and technological talents and engineers of excellence, a full range of strategic talent force. Data show that China’s science and technology, agriculture and medicine graduates have exceeded 2.5 million people. Not only is there a rich reserve of scientific and technological talent resources, but the international academic influence of top scientific and technological talents continues to improve, with more and more Chinese scientists moving to the center of the international academic stage, and the number of highly cited scientists in the world increasing from 111 in 2014 to 1,169 in 2022, ranking second in the world. More outstanding young scientific and technological talents are taking the lead in major national scientific and technological tasks, and more than 80% of the researchers under 45 years old in the National Key R&D Program are researchers. (Note: “Full-time equivalent of R&D personnel” is an internationally recognized indicator for comparing scientific and technological manpower inputs, referring to the workload of R&D personnel calculated on the basis of the time they actually spend on R&D activities, and the unit is “person-year”.)

A modified insulin regulates insulin secretion dynamically: animal experiments

https://www.nature.com/articles/s41551-023-01138-7 https://spc.jst.go.jp/news/231202/topic_3_05.html A team led by Professor Gu Sheng from Zhejiang University School of Pharmacy and Jinhua Research Institute has developed a long-acting insulin formulation. The drug senses fluctuations in blood glucose levels and dynamically regulates insulin secretion to control blood glucose levels for a long period of time. Beta cells in the human body can sense the concentration of glucose and regulate the rate of glucose metabolism in the body by controlling the amount of insulin secreted. Diabetics, however, may lack beta cells or be insensitive to insulin, making it difficult for them to maintain normal blood glucose levels. The new complex developed by the team is made by tightly coupling gluconic acid-modified recombinant human insulin with phenylboronic acid-modified polylysine. When injected subcutaneously, the new complex acts like an insulin “reservoir,” storing insulin under the skin for a long period of time and rapidly secreting it when blood glucose levels rise. This new complex changes the difficulties of conventional insulin preparations, which are prone to leakage and difficult to treat over a long period of time. Under normal blood glucose conditions, it can slowly release small amounts of insulin, maintaining basic blood glucose stability. On the other hand, as blood glucose levels rise, glucose competitively binds to the “suckers” in the complex, rapidly releasing insulin and bringing blood glucose levels back into the normal range. In previous experiments, a single dose of the drug was sufficient to maintain normal blood glucose levels for more than a week in a 30-kilogram model pig with type 1 diabetes, and it did not produce hypoglycemic symptoms.

Synthetic autotrophic systems for CO2 assimilation

https://www.sciencedirect.com/science/article/abs/pii/S073497502300201X?via%3Dihu https://www.cas.cn/syky/202312/t20231205_4990251.shtml In the field of synthetic biology, artificial carbon assimilation pathways and artificial autotrophic systems are  expected to contribute to the response to the environmental crisis and the promotion of sustainable material production. Achievements in this process, whether based on experience or model predictions, have contributed to the advancement of the field as a whole. As the cornerstone of biochemical reactions, enzymes have an important role in pathway implementation. At the same time, natural enzyme libraries offer a wide range of possibilities for mining pan-substrate activity or new functional mutants. Over the past decade, non-oxidative enzymes have stood out for their low-carbon profile and continue to show value in chassis development and product synthesis. Thus, summarizing and reviewing research advances in the field of artificial autotrophy can help readers identify potential research models and deepen their thinking when designing and selecting artificial pathways and their host systems. Essentially, the artificial carbon assimilation pathway corresponds to the dark reaction of photosynthesis, while its energy supply strategy corresponds to the light reaction. With the continuous adaptation of the two, artificial autotrophic systems will gradually evolve into innovative producers for industrial and environmental applications. In a recent review in Biotechnology Advances the role of unnatural reactions and pathways in the development of artificial autotrophic systems were summarised. The Chinese reference contains appropriate graphs.  

Cell-wall based leaching of Ce(III)

https://www.sciencedirect.com/science/article/abs/pii/S138589472304799X?via%3Dihub https://www.cas.cn/syky/202312/t20231205_4990265.shtml Researchers at the CAS QIBEBT in Qingdao have developed a new type of biomimetic adsorbent material for the green and efficient adsorption of low-concentration rare earth ions from leach tailings in rare earth mining areas based on the enrichment motifs of the rare earth super-enriched plants- In this work, a novel cellulose/pectin composite aerogel adsorbent based on ultra-enriched plant cell walls for effective rare earth enrichment was prepared for the recovery of rare earth elements in leach tailings, and the main components of the resulting adsorbent were systematically analyzed using SEM, FTIR, XRD and contact angle measurement instrument. The results showed that the PCA adsorbent surface has an excellent structural basis in the field of adsorption of rare earth ions with abundant active adsorption groups, low crystallinity and good hydrophilic properties. The thermodynamic study showed that the adsorption process conformed to the Langmuir model, and the theoretical maximum adsorption capacity reached 337 mg/g. The kinetic study showed that the adsorption process conformed to the quasi-secondary kinetic model, and the adsorption process was chemisorption. The adsorbent still had good adsorption performance after five adsorption-desorption cycles. From the FTIR and XPS spectral analysis, it is clear that the adsorption mechanism of PCA for rare earth ions is mainly realized by electrostatic interaction, ion exchange with -COOH and chelation with C-NH2. The novel composite aerogel PCA based on cell wall synthesis has potential application prospects as a green and efficient adsorbent with good regeneration performance.

USTC: programmable artificial photosynthetic cells

https://www.cas.cn/syky/202312/t20231208_4990877.shtml https://doi.org/10.1038/s41467-023-42591-x Compared with natural photosynthetic organisms, editable artificial photosynthetic cells are able to convert CO2 into customizable high value-added fuels and chemicals more efficiently through rational design. In addition, artificial photosynthetic cells are the key to ultimately mimic the tissue morphology and characteristics of natural photosynthetic organisms, opening the way to building devices for practical applications. However, the realization of this concept hinges on cofactors that are critical for CO2 reductase catalysis, but is limited by the regenerative capacity of multiple cofactors. Recently, a research team at the University of Science and Technology of China (USTC) created an artificial photosynthetic cell containing a bio-abiotic hybridized energy module, which enhances the regenerative capacity of multiple biologically active cofactors and provides a more versatile platform for editable artificial photosynthetic cells. This artificial photosynthetic cell can achieve editable capabilities by coupling with diverse reductases, enabling customizable CO2 conversion. The research results were published in Nature Communications. In this study, an efficient energy module based on hybridization of biological vesicles and inorganic quantum dots was designed. This design facilitated proton-coupled electron transfer and significantly enhanced the regeneration of biologically active NADPH, NADH, and ATP cofactors without the need for external material supplementation. This bio-abiotic hybridization platform can be further coupled to a variety of NADPH, NADH and ATP-dependent CO2 reductases to selectively convert CO2 into carbon-based products. The study constructed artificial photosynthetic cells by loading energy modules, bioenzymes and cofactors via microfluidics to achieve controlled CO2 conversion.

2023/12 The YAO genome: a more accurate genome sequence for the Han population

https://www.sciencedirect.com/science/article/pii/S1672022923001006 http://en.people.cn/n3/2023/1212/c90000-20109305.html A team of geneticists has assembled a complete human genome reference for Han Chinese, the first of its kind and which could potentially promote precision medicine in China. The telomere-to-telomere (T2T) gapless diploid genome sequence of a healthy male individual, named T2T-YAO, contained two complete sets of chromosomes, one from each parent, and the Y-chromosome that passes only from male parents to male offspring. A similar work, T2T-CHM13, published in 2022 by the U.S. National Institutes of Health, fulfilled 8 percent of the previously unknown highly repetitive region in the human genome. However, it was of European-origin and without the Y-chromosome, thus not enough for representing all individuals worldwide. The scientists from Peking University People’s Hospital and Beijing Institute of Genomics (BIG) under the Chinese Academy of Sciences, collected samples from an ancient village in Hongtong County in Shanxi Province in the north of China, a place believed to be a starting point of the countrywide mass migration in around the late 14th century. The YAO part of the name stems from the sampling point located near the ruins of the capital of the legendary Chinese emperor Yao, while T2T stands for telomere-to-telomere or end-to-end sequence of all chromosomes in the genome. A comparative analysis conducted by the Chinese team has revealed that about 11 percent of YAO’s genome is not alignable to that of T2T-CHM13, with about 3,000 different genes in each genome, a discrepancy much wider than previously estimated, said Gao Zhancheng from Peking University People’s Hospital, the paper’s correspondence author. The significant discrepancies between the individual genomes of the two human populations in the study are mainly attributed to the mass of non-coding DNA, accounting for nearly 99 percent of the genome, he added. Recently, some of those non-coding DNA sequences were found to serve important functional roles, such as in the regulation of gene expression, while the functions of other non-coding DNA remain unknown. Gao and his collaborators have found that YAO is mostly of East Asian origin and admixed with sporadic predicted markers of South Asia, Europe, and America. The markers from South Asia are a little more than those stemming from Europe and America, revealing greater genetic exchange between the East Asian and South Asian ethnic groups, according to the study. In addition, the haplotype of Y-chromosome in YAO, a predominant type in China and Asia, has also been identified in ancient DNA samples from a Neolithic site in the nearby Shaanxi Province dating back to approximately 4,000 years ago, which suggests a potential genetic continuity in the region from the earliest days of human habitation in this part of China. The reference human genome is known as a genetic “navigation map” widely used in human genetics and medical research, and the great genome discrepancies among ethnic groups suggest that YAO is a more appropriate reference genome for Han Chinese. The YAO genome can thus provide more accurate gene and mutation information for the Han Chinese population in establishing a technical system and quality benchmark for clinical research such as genetic disease diagnosis, disease risk prediction, cancer studies, and precision medicine in China.

CAS IPE develops protein-based inhaled vaccine

http://en.people.cn/n3/2023/1214/c90000-20110387.html https://www.nature.com/articles/d41586-023-03557-7 Researchers from the CAS Institute of Process Engineering (IPE)  have proposed a new “nano-micro composite” delivery concept for vaccines and developed a single-dose, dry-powder, inhalable vaccine platform. The vaccine made in the laboratory based on the technology is effective in blocking respiratory viral infection and transmission in animal test, showing great promise for combating future emerging and epidemic infectious diseases. In recent years, researchers have made significant progress in developing vaccines for infectious respiratory diseases. However, most of these vaccines are administered through intramuscular injection, which primarily induces a humoral immune response and relies on blood antibodies to neutralize the virus. This approach fails to trigger a mucosal immune response and establish a robust immune barrier in the respiratory tract. The current liquid form of vaccines requires to be stored in strict low-temperature, and the two- or three-dose vaccination schedule also impacts the overall vaccination rate. In confronting these problems, professor Wei Wei and professor Ma Guanghui from the State Key Laboratory of Biochemical Engineering at IPE, in cross-disciplinary collaboration with professor Wang Hengliang and professor Zhu Li from the State Key Laboratory of Pathogen and Biosecurity, have developed a new vaccine platform. This platform combines biodegradable microspheres with protein nanoparticles. The surface of these nanoparticles can simultaneously display multiple antigens, thus inducing a broad-spectrum immune response and expanding the range of vaccine protection. The platform also allows for the quick and convenient development of other respiratory virus vaccines due to the flexibility of antigen presentation. The platform’s unique nano-micro composite structure enables an efficient immune response in the lungs by facilitating high-performance delivery. Once antigen-nanoparticles are released, they can be efficiently taken up by antigen-presenting cells. Moreover, this dry powder vaccine significantly reduces storage and transportation costs, making it suitable for areas with limited refrigeration facilities, thus improving immunization rates. “The components of this nano-micro system used natural proteins and approved polymer materials, and the effectiveness and safety of the vaccine have been systematically studied in non-human primates, indicating its great potential for clinical translation,” professor Wei said. Developers hope that vaccines that prime immune cells in the mucous membranes that live in the nose and mouth, where SARS-CoV-2 enters the body, will quickly stop the virus from spreading, preventing even mild cases and blocking transmission. More than 100 oral or nasal vaccines are in development globally.

Scroll to top